Author:
Liu Enjie,Xie Ao-Ji,Zhou Qiuzhi,Li Mengzhu,Zhang Shujuan,Li Shihong,Wang Weijin,Wang Xiaochuan,Wang Qun,Wang Jian-Zhi
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Llorens-Martin, M., Jurado, J., Hernandez, F. & Avila, J. GSK-3beta, a pivotal kinase in Alzheimer disease. Frontiers in molecular neuroscience 7, 46 (2014).
2. Wang, J. Z., Wang, Z. H. & Tian, Q. Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer’s disease. Neuroscience bulletin 30, 359–366 (2014).
3. Beurel, E., Grieco, S. F. & Jope, R. S. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacology & therapeutics 148, 114–131 (2015).
4. Pei, J. J. et al. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. Journal of neuropathology and experimental neurology 56, 70–78 (1997).
5. Zhu, L. Q. et al. GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. The Journal of neuroscience 30, 3624–3633 (2010).
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献